Adenovirus/PSA Vaccine

BIOLOGICAL2 trials

Sponsors

David M Lubaroff

Conditions

Hormone Refractory Prostate CancerRecurrent Prostate Cancer

Phase 2

Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21

CompletedNCT00583752

David M LubaroffRecurrent Prostate Cancer

Start: 2007-12-31End: 2023-01-31Updated: 2023-05-18

Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer

CompletedNCT00583024

David M LubaroffHormone Refractory Prostate Cancer

Start: 2007-12-31End: 2023-01-31Updated: 2023-04-28

Related Papers

Time to biochemical and radiographic progression in patients treated with adenovirus-PSA vaccine for non-metastatic/early metastatic castrate-resistant prostate cancer: Phase 2 trial results.

Journal of Clinical Oncology2015-05-202 citations